Evidence map›Paper›PMID 35662656›Full record

ArticleThe Journal of allergy and clinical immunology2022

Chronic rhinosinusitis: Future treatments and unmet needs.

Sneha Giri, Alexander L Schneider, Bruce K Tan

Abstract readEditorial
In one paragraph

Article in The Journal of allergy and clinical immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Sleep disruption in chronic rhinosinusitis improves using exhalation-delivery nasal steroid therapy.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sneha GiriDepartment of Otolaryngology-Head and Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, Ill.
Alexander L SchneiderDepartment of Otolaryngology-Head and Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, Ill.
Bruce K TanDepartment of Otolaryngology-Head and Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, Ill. Electronic address: b-tan@northwestern.edu.

Funding

Population-based CRS epidemiology: sex differences, natural history, and long-term outcomes based on clinically-defined phenotypes and biologically-based endotypes - GeisingerP01AI145818 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KERN, ROBERT C · 2019 to 2023
$9.3M
Type-2 inflammation mediates olfactory loss in Chronic Rhinosinusitis: mechanisms and therapeutic opportunitiesR01DC016645 · NIDCD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI TAN, BRUCE K · 2018 to 2022
$3.0M
Autoantibody mediated pathogenesis in chronic rhinosinusitis with nasal polyps: mechanisms and consequencesR01AI134952 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI TAN, BRUCE K · 2018 to 2022
$2.0M
NIAID NIH HHS P01 AI145818NIAID NIH HHS R01 AI134952NIDCD NIH HHS R01 DC016645
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

RhinitisSinusitisChronic DiseaseEndoscopyHumansbiologicsChronic rhinosinusitisendoscopic sinus surgerytype 2 inflammation

Identifiers

PMID35662656
PMCPMC9552525

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.